Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ruizhan, Tong"'
Autor:
Qiuchan Xiong, Caojie Liu, Xin Zheng, Xinyi Zhou, Kexin Lei, Xiaohan Zhang, Qian Wang, Weimin Lin, Ruizhan Tong, Ruoshi Xu, Quan Yuan
Publikováno v:
International Journal of Oral Science, Vol 14, Iss 1, Pp 1-10 (2022)
Abstract The dorsal lingual epithelium, which is composed of taste buds and keratinocytes differentiated from K14+ basal cells, discriminates taste compounds and maintains the epithelial barrier. N6-methyladenosine (m6A) is the most abundant mRNA mod
Externí odkaz:
https://doaj.org/article/a4da72e1621e4416a550eafa9bcbd14d
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Cancer stem cells, a relatively small group of self-renewing cancer cells, were first isolated from acute myeloid leukemia. These cells can play a crucial role in tumor metastasis, relapse, and therapy resistance. The cancer stem cell theory may be a
Externí odkaz:
https://doaj.org/article/604718362e914e7c8b74fe873551426a
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss , Pp 359-370 (2019)
The expanding CRISPR-Cas9 technology is an easily accessible, programmable, and precise gene-editing tool with numerous applications, most notably in biomedical research. Together with advancements in genome and transcriptome sequencing in the era of
Externí odkaz:
https://doaj.org/article/a5bc77d11381401f8eff207195c2c7bf
Autor:
Yuncong Liu, Li Wu, Ruizhan Tong, Feiyue Yang, Limei Yin, Mengqian Li, Liting You, Jianxin Xue, You Lu
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Cervical cancer is one of the most common gynecological tumors, and the majority of early-stage cervical cancer patients achieve good recovery through surgical treatment and concurrent chemoradiotherapy (CCRT). However, for patients with recurrent, p
Externí odkaz:
https://doaj.org/article/955fa2ef24c24d5aa9e863a620b362c2
Autor:
Rui Li, Limei Yin, Sun Chuntang, Kemin Li, Jianxin Xue, Ruizhan Tong, Rutie Yin, Zhipeng Zhou, Y. Liu, You Lu, Pansong Li
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:1432-1441
Purpose This work assessed local and systemic alternations of the tumor immune microenvironment during concurrent chemoradiation therapy (CCRT) of local advanced cervical cancer to estimate the optimal timing for immune therapy in relation to CCRT. M
Autor:
Qiuchan, Xiong, Caojie, Liu, Xin, Zheng, Xinyi, Zhou, Kexin, Lei, Xiaohan, Zhang, Qian, Wang, Weimin, Lin, Ruizhan, Tong, Ruoshi, Xu, Quan, Yuan
Publikováno v:
International journal of oral science. 14(1)
The dorsal lingual epithelium, which is composed of taste buds and keratinocytes differentiated from K14
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss, Pp 359-370 (2019)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
The expanding CRISPR-Cas9 technology is an easily accessible, programmable, and precise gene-editing tool with numerous applications, most notably in biomedical research. Together with advancements in genome and transcriptome sequencing in the era of
Autor:
Jingjing Luo, Hongmei Zhou, Fanglong Wu, Xiaoyu Li, Ruizhan Tong, Yangfan Liu, Miao Yang, Jin Yang, Yang Wu, Wei Zhao, Yuan Tian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93ff4599436f5fa8b202f55327f0b6b7
https://doi.org/10.1111/odi.13979/v2/response1
https://doi.org/10.1111/odi.13979/v2/response1
Autor:
Limei Yin, Wenbo Wang, Zhuoran Yao, Jianxin Xue, Ruizhan Tong, Hui Wang, Shuangsi Liao, Laduona Wang, Yue Zheng, Feifei Na, Min Yu, Xuanwei Zhang, Youling Gong, Meijuan Huang, Xianming Mo, Chong Chen, You Lu
Publikováno v:
Cancer Research. 82:5569-5569
The therapeutic efficacy of CAR-T cells in solid tumors, unlike in hematologic tumor, is greatly limited by the insufficient infiltration and persistence of CAR-T cells as well as the immunosuppressive tumor microenvironment. The aim of this study wa
Autor:
Hui Wang, Min Yu, Feifei Na, Limei Yin, Lin Zhou, Zhuoran Yao, Xiangyu Pan, Xuanwei Zhang, Lin Chen, Yanying Li, Bingwen Zou, Youling Gong, Jiang Zhu, Yongmei Liu, Linglu Yi, Ruizhan Tong, Jianxin Xue, Meijuan Huang, Chong Chen, You Lu
Publikováno v:
Journal of Clinical Oncology. 40:e20608-e20608
e20608 Background: Immune checkpoint inhibitors (ICIs) provide a durable and long-term benefit but still unsatisfactory clinical efficacy for extensive-stage small cell lung cancer (ES-SCLC). An optimized dose and schedule of radiotherapy for ES-SCLC